Nanobiotix SA
PAR:NANO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lifezone Metals Ltd
NYSE:LZM
|
IM |
|
C
|
CNlight Co Ltd
SZSE:002076
|
CN |
|
Electrolux Professional AB (publ)
STO:EPRO B
|
SE |
Nanobiotix SA
EPS (Diluted)
Nanobiotix SA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Nanobiotix SA
PAR:NANO
|
EPS (Diluted)
€0
|
CAGR 3-Years
33%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
|
|
Valneva SE
PAR:VLA
|
EPS (Diluted)
€0
|
CAGR 3-Years
18%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-9%
|
|
|
G
|
Genfit SA
PAR:GNFT
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-53%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-10%
|
|
|
Inventiva SA
PAR:IVA
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
DBV Technologies SA
PAR:DBV
|
EPS (Diluted)
-$1
|
CAGR 3-Years
5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
7%
|
|
|
Abivax SA
PAR:ABVX
|
EPS (Diluted)
-€4
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
Nanobiotix SA
Glance View
Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 100 full-time employees. The company went IPO on 2012-10-29. The firm is engaged in developing nanoparticle technology. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The firm develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives the systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
See Also
What is Nanobiotix SA's EPS (Diluted)?
EPS (Diluted)
-0.5
EUR
Based on the financial report for Dec 31, 2025, Nanobiotix SA's EPS (Diluted) amounts to -0.5 EUR.
What is Nanobiotix SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
8%
Over the last year, the EPS (Diluted) growth was 65%. The average annual EPS (Diluted) growth rates for Nanobiotix SA have been 33% over the past three years , 18% over the past five years , and 8% over the past ten years .
